Literature DB >> 16019035

The pharmacokinetics and tissue distribution of sinomenine in rats and its protein binding ability in vitro.

Zhong-Qiu Liu1, Kelvin Chan, Hua Zhou, Zhi-Hong Jiang, Yuen-Fan Wong, Hong-Xi Xu, Liang Liu.   

Abstract

Sinomenine, an alkaloid derived from the Chinese medical plant Sinomenium acutum, was studied with regard to its pharmacokinetics and tissue distribution in rats, and to its protein binding ability in the plasma of rats and rabbits and in the solutions of albumin and alpha-1-acid-glycoprotein. An HPLC analytical method was developed for determining sinomenine. The results demonstrated that oral administration with a single dosage at a rate of 90 mg sinomenine/kg in rats achieved about 80% bioavailability, while most of the other pharmacokinetic parameters were similar to the data from the animals treated intravenously. This indicates that oral administration of sinomenine would be appropriate in clinics. In rats, at 45 min after oral dosage, the drug was found to distribute widely in the internal organs, with tissue concentrations (from highest to lowest) in the order of kidneys, liver, lungs, spleen and heart, brain and testicles. At 90 min after dosing, the tissue concentrations in the organs were markedly decreased. The liver and kidneys manifested as the dominant organs with high tissue concentrations that might be responsible for metabolism and elimination of sinomenine. Examination of the protein binding ability showed that sinomenine with 4 microg/ml concentration in the plasma of rats and rabbits or in the albumin solution achieved a protein binding rate of more than 60%, while in the solution of alpha-1-acid-glycoprotein the rate was only about 33%. This result suggests that sinomenine might have much more potent binding ability with albumin than with alpha-1-acid-glycoprotein, resulting from its acidic property.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019035     DOI: 10.1016/j.lfs.2005.05.054

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  HPLC and LC-MS analysis of sinomenine and its application in pharmacokinetic studies in rats.

Authors:  Li-hong Long; Peng-fei Wu; Xiang-long Chen; Zui Zhang; Yu Chen; Yi-yong Li; You Jin; Jian-guo Chen; Fang Wang
Journal:  Acta Pharmacol Sin       Date:  2010-09-27       Impact factor: 6.150

2.  Sinomenine reduces invasion and migration ability in fibroblast-like synoviocytes cells co-cultured with activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, CD147.

Authors:  Yangqiong Ou; Weidong Li; Xuejun Li; Zhibin Lin; Min Li
Journal:  Rheumatol Int       Date:  2010-05-16       Impact factor: 2.631

3.  Sinomenine inhibits microglial activation by Aβ and confers neuroprotection.

Authors:  Shilpa Mishra Shukla; Shiv K Sharma
Journal:  J Neuroinflammation       Date:  2011-09-14       Impact factor: 8.322

4.  Sinomenine Protects PC12 Neuronal Cells against H2O2-induced Cytotoxicity and Oxidative Stress via a ROS-dependent Up-regulation of Endogenous Antioxidant System.

Authors:  Hua Fan; Qing Shu; Xinlei Guan; Jiegang Zhao; Junqiang Yan; Xiangming Li; Jiangbo Liu; Zhaohui Jia; Jian Shi; Juan Li
Journal:  Cell Mol Neurobiol       Date:  2017-02-03       Impact factor: 5.046

5.  Sex-related differences in safety profiles, pharmacokinetics and tissue distribution of sinomenine hydrochloride in rats.

Authors:  Hong Huang; Er-Bing Zhang; Ou-Yang Yi; Han Wu; Guiming Deng; Yu-Ming Huang; Wen-Liang Liu; Jian-Ye Yan; Xiong Cai
Journal:  Arch Toxicol       Date:  2022-08-30       Impact factor: 6.168

6.  Cardiovascular pharmacology of sinomenine: the mechanical and electropharmacological actions.

Authors:  Seiichiro Nishida; Hiroyasu Satoh
Journal:  Drug Target Insights       Date:  2007-04-18

7.  Comparative pharmacokinetics study of sinomenine in rats after oral administration of sinomenine monomer and Sinomenium acutum extract.

Authors:  Mao-Fan Zhang; Yan Zhao; Kun-Yu Jiang; Long Han; Xiao-Yue Lu; Xin Wang; Lan Zuo; Sheng-Nan Meng
Journal:  Molecules       Date:  2014-08-12       Impact factor: 4.411

8.  An ultra-high performance liquid chromatographic-tandem mass spectrometric method for the determination of sinomenine in human plasma after transdermal delivery of the zhengqing fengtongning injection.

Authors:  Tingbo Chen; Zheng Xiang; Gengting Dong; Pei Luo; Ping Qiu; Shenzhi Wang; Baoming Huang; Yingyi Wen; Feichi Wu; Liang Liu; Hua Zhou
Journal:  Molecules       Date:  2015-04-10       Impact factor: 4.411

9.  Controlled release of optimized electroporation enhances the transdermal efficiency of sinomenine hydrochloride for treating arthritis in vitro and in clinic.

Authors:  Shun Feng; Lijun Zhu; Zhisheng Huang; Haojia Wang; Hong Li; Hua Zhou; Linlin Lu; Ying Wang; Zhongqiu Liu; Liang Liu
Journal:  Drug Des Devel Ther       Date:  2017-06-15       Impact factor: 4.162

Review 10.  Study on the interaction between active components from traditional Chinese medicine and plasma proteins.

Authors:  Qishu Jiao; Rufeng Wang; Yanyan Jiang; Bin Liu
Journal:  Chem Cent J       Date:  2018-05-04       Impact factor: 4.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.